logo.png
Cellect Biotechnology Commences Collaboration with XNK Therapeutics to Advance Novel NK Cell-Based Therapies; Adds Another Partner for its Functional Cell Selection Technology
October 29, 2020 08:00 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel , Oct. 29, 2020 (GLOBE NEWSWIRE) -- Adding to a growing roster of partners, Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced that it has entered into and commenced a...
logo.png
Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraft
October 22, 2020 08:00 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating...
logo.png
Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa
September 21, 2020 08:30 ET | Cellect Biotechnology Ltd.
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations Tel Aviv, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) --...
logo.png
Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19
May 21, 2020 16:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, today...
logo.png
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
May 12, 2020 08:48 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today...
logo.png
Cellect Biotechnology Announces Receipt of Nasdaq Minimum Bid Price Notification
May 16, 2019 07:00 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel, May 16, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced today it has received notification...
logo.png
Cellect Biotechnology to Explore Strategic Alternatives to Maximize Shareholder Value
May 16, 2019 07:00 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel, May 16, 2019 (GLOBE NEWSWIRE) -- Following a review of its business, including the status of its clinical and development programs, resources and capabilities, Cellect...
logo.png
Cellect Announces Closing of $6.5 Million Underwritten Public Offering
February 13, 2019 17:00 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the closing of its previously...
cellectenablingstemcells_logo.jpg
Cellect Announces Pricing of $6.5 Million Public Offering
February 08, 2019 00:55 ET | Cellect Biotechnology Ltd.
Tel Aviv, Israel, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced the pricing of an underwritten...
Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S.
May 03, 2017 07:01 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cell isolation technology, announced today that the U.S. Food & Drug...